Scientists from the German Cancer Research Centre have developed a vaccine that helps the immune system fight cancer, contributing to the recovery of the disease. The vaccine had 93 percent success in the first experiments conducted on humans.
Cancer is one of the diseases that humanity is working hard to find a cure for today. Although there are different treatment methods for increasing cancer cases all over the world, yet a vaccine or treatment is not available that completely eliminates the disease, but scientists continue to search for a cure for this disease.
Cancer, which until a few years ago had little hope for its treatment and was one of the biggest problems for the whole world, has recently come to the agenda with vaccine studies. In fact, we can say that this is an indication of how much has been taken in relation to one of the most frightening diseases that humanity has ever encountered. Scientists from the German Cancer Research Center are also conducting research on vaccines for cancer, and the news is very promising.
The success rate in the first experiments on humans is 93 percent
Scientists from the German Research Centre, one of Germany’s largest research centers, have developed a vaccine that will help the immune system more easily identify malignant tumors found in the brain as it struggles with cancerous cells. As a result of tests, it was discovered that the immune response triggered by the vaccine, which was found to be safe, can significantly slow down the progression of the tumor.
In the first experiments conducted on people with cancer, it was announced that this new and experimental vaccine had 93 percent success. After vaccination, the growth rate of cancerous tumors slowed. Research on the vaccine, which also shows that our immune system can help cure cancer, is ongoing, and experiments will be conducted on larger groups.
